153 related articles for article (PubMed ID: 22910403)
1. Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis.
Faridi K; Joober R; Malla A
Schizophr Res; 2012 Oct; 141(1):78-82. PubMed ID: 22910403
[TBL] [Abstract][Full Text] [Related]
2. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
[TBL] [Abstract][Full Text] [Related]
3. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study).
Baeza I; Graell M; Moreno D; Castro-Fornieles J; Parellada M; González-Pinto A; Payá B; Soutullo C; de la Serna E; Arango C
Schizophr Res; 2009 Sep; 113(2-3):129-37. PubMed ID: 19427172
[TBL] [Abstract][Full Text] [Related]
4. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
[TBL] [Abstract][Full Text] [Related]
5. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
Machielsen M; van der Sluis S; de Haan L
Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
[TBL] [Abstract][Full Text] [Related]
6. Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Psychiatry Res; 2017 Sep; 255():36-41. PubMed ID: 28521146
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.
Miller R; Ream G; McCormack J; Gunduz-Bruce H; Sevy S; Robinson D
Schizophr Res; 2009 Sep; 113(2-3):138-44. PubMed ID: 19481424
[TBL] [Abstract][Full Text] [Related]
8. Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis.
Malcolm CP; Picchioni MM; DiForti M; Sugranyes G; Cooke E; Joseph C; McQueen G; Paparelli A; Stilo S; O'Connor J; Morgan C; Murray RM; Hodgins S
Schizophr Res; 2011 Mar; 126(1-3):81-6. PubMed ID: 21186097
[TBL] [Abstract][Full Text] [Related]
9. Cannabis use and anticipatory pleasure as reported by subjects with early psychosis and community controls.
Cassidy CM; Lepage M; Harvey PO; Malla A
Schizophr Res; 2012 May; 137(1-3):39-44. PubMed ID: 22436394
[TBL] [Abstract][Full Text] [Related]
10. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
[TBL] [Abstract][Full Text] [Related]
11. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
[TBL] [Abstract][Full Text] [Related]
12. Change in cannabis use in the general population: a longitudinal study on the impact on psychotic experiences.
van Gastel WA; Vreeker A; Schubart CD; MacCabe JH; Kahn RS; Boks MP
Schizophr Res; 2014 Aug; 157(1-3):266-70. PubMed ID: 24930951
[TBL] [Abstract][Full Text] [Related]
13. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
[TBL] [Abstract][Full Text] [Related]
14. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder.
Toftdahl NG; Nordentoft M; Hjorthøj C
J Dual Diagn; 2016; 12(2):129-36. PubMed ID: 27070732
[TBL] [Abstract][Full Text] [Related]
16. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.
Hides L; Dawe S; Kavanagh DJ; Young RM
Br J Psychiatry; 2006 Aug; 189():137-43. PubMed ID: 16880483
[TBL] [Abstract][Full Text] [Related]
17. Impact of symptom resolution on medication adherence in first episode psychosis.
Steger KA; Cassidy C; Rabinovitch M; Joober R; Malla A
Psychiatry Res; 2012 Mar; 196(1):45-51. PubMed ID: 22377571
[TBL] [Abstract][Full Text] [Related]
18. Childhood symptoms of inattention-hyperactivity predict cannabis use in first episode psychosis.
Cassidy CM; Joober R; King S; Malla AK
Schizophr Res; 2011 Nov; 132(2-3):171-6. PubMed ID: 21778038
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis.
Edwards J; Elkins K; Hinton M; Harrigan SM; Donovan K; Athanasopoulos O; McGorry PD
Acta Psychiatr Scand; 2006 Aug; 114(2):109-17. PubMed ID: 16836598
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
Arnold C; Allott K; Farhall J; Killackey E; Cotton S
Schizophr Res; 2015 Oct; 168(1-2):231-7. PubMed ID: 26260081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
